| 前收市價 | 1.9000 |
| 開市 | 1.9000 |
| 買盤 | 0.0000 x 0 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 1.7500 - 1.9000 |
| 52 週波幅 | 0.7300 - 6.3900 |
| 成交量 | |
| 平均成交量 | 61,035 |
| 市值 | 41.439百萬 |
| Beta 值 (5 年，每月) | 0.62 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1.3500 |
| 業績公佈日 | 2024年11月07日 - 2024年11月11日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 1.50 |
ZacksAccelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
AXDX's Arc system gains FDA clearance, automating blood culture prep for faster microbial ID, improved sepsis outcomes and reduced hospital costs.
ZacksAccelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
Accelerate Diagnostics (AXDX) is confident about WAVE product design and the system's capabilities after the successful completion of the pre-clinical trial.
ZacksAccelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 9.09% and 0.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
